Banon IVF Center Assiut, Egypt
10
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Triple-arm pH Comparison
Role: collaborator
Varicocele Repair for Men Undergoing IVF/ICSI
Role: collaborator
Effect of Protein Concentration on Human Embryo Development
Role: collaborator
Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years
Role: collaborator
Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation
Role: collaborator
Improving Embryogenesis by Adding Growth Factors to In Vitro Human Culture Media
Role: collaborator
Novel Approach With Double Agent Artificial Oocyte Activation for Repeated Fertilization Failure Due to Combined Sperm and Oocyte Factor
Role: collaborator
Artificial Oocyte Activation Comparing Tow Different Agents
Role: collaborator
Adding Insulin to IVF Culture Media Significantly Improve Outcome
Role: collaborator
Novel Approach for Embryo Transfer Medium by Adding Cytokine to Hyaluronan Enriched Embryo Transfer Medium (Embryo Glue)
Role: collaborator
All 10 trials loaded